Potential Of Hibiscus (Hibiscus rosa sinensis L.) Ethanol Extract As Root Canal Medicament Materials

Authors

  • Efika Choirunnisa Department of Dentistry Faculty of Medicine Diponegoro University, Semarang, Indonesia, Indonesia
  • Gustantyo Wahyu Wibowo Dr. Kariadi Hospital, Semarang,Indonesia, Indonesia
  • Arlita Leniseptaria Antari Department of Microbiology Faculty of Medicine Diponegoro University Semarang, Indonesia, Indonesia
  • Brigitta Natania Renata Purnomo Department of Dentistry Faculty of Medicine Diponegoro University, Semarang, Indonesia, Indonesia

DOI:

https://doi.org/10.36408/mhjcm.v10i1.809

Keywords:

H. rosa sinensis L, E. faecalis, root canal medicaments, MIC, inhibition ability

Abstract

BACKGROUND: Enterococcus faecalis is the dominant bacteria found in root canals, especially in failure of root canal treatment. Therefore, antibacterial agents are required as a means to achieve complete disinfection of the root canal system. One of the natural ingredients that has been proven to have antibacterial properties is the ethanol extract of hibiscus (H. rosa sinensis L.), so it has the potential to be used as a root canal medicament to inhibit growth and eliminate E. faecalis bacteria.  

OBJECTIVE: Testing the effectiveness of hibiscus (H. rosa sinensis L.) ethanol extract as a potential root canal medicament.

METHOD: The study was conducted using a true experimental post-test only control group design in 6 treatment groups with various concentrations of hibiscus extract (100%, 50%, 25%, 12.5%, 6.25, and 3.125%) and a positive control group. (Brain Heart Infusion added E. faecalis) and negative (Brain Heart Infusion). The extract was then diluted to the concentration used and added with 1.5x108CFU/ml E. faecalis and then cultured using the spread method on NA media, incubated anaerobically at 37oC for 24 hours, then the colonies that grew were counted using a colony counter.

RESULT: The results showed that 100% concentration had the highest ability to inhibit the growth of E. faecalis bacteria (92.7%) with an average number of colonies growing of 4.4 x 102 CFU/ml. The minimum inhibitory concentration (MIC) was shown at a concentration of 50%, with an inhibiting ability of 90.17% and the average number of colonies that grew was 5.9 x103 CFU/ml. Kruskal Wallis statistical test showed a significant difference in the number of colonies (p<0.05).

CONCLUSION: Hibiscus extract with a concentration of 100% has the highest ability to inhibit the growth of E. faecalis bacteria and MIC is present at a concentration of 50%.

Downloads

Download data is not yet available.

References

  1. Ruddle CJ. Endodontic triad for success: The role of minimally invasive technology. Dent Today. 2015;34(5):1–7.
  2. Eldina F, dan Wignyo H. Studi Kasus Restorasi Pasca One Visit Endodontik dengan Perbaikan Malposisi dan Selective Contouring Eldina. MKGK Clinical Dental Journal. 2016; 2(1): 32-38.
  3. Tabassum S, Khan FR. Failure of endodontic treatment: The usual suspects. Eur J Dent. 2016;10(1):144–7.
  4. Iqbal A. The factors responsible for endodontic treatment failure in the permanent dentitions of the patients reported to the college of dentistry, the university of Aljouf, Kingdom of Saudi Arabia. J Clin Diagnostic Res. 2016;10(5):ZC146–8.
  5. Fouad AF. Endodontic Microbiology. Second edition. | USA : John Wiley & Sons Inc., 2017.
  6. Wong J, Manoil D, Näsman P, Belibasakis GN, Neelakantan P. Microbiological Aspects of Root Canal Infections and Disinfection Strategies: An Update Review on the Current Knowledge and Challenges. Front Oral Heal. 2021;2(June).
  7. Wang QQ, Zhang CF, Chu CH, Zhu XF. Prevalence of Enterococcus faecalis in saliva and filled root canals of teeth associated with apical periodontitis. Int J Oral Sci. 2012;4(1):19–23.
  8. Kranz S, Guellmar A, Braeutigam F, et al. Antibacterial effect of endodontic disinfections on enterococcus faecalis in dental root canals—an in-vitro model study. Materials (Basel). 2021;14(9).
  9. Alrahman MSA, Faraj BM, Dizaye KF. Assessment of Nitrofurantoin as an Experimental Intracanal Medicament in Endodontics. Biomed Res Int. 2020;2020.
  10. Permatasari R, Irbahani M. Pemilihan Medikamen Intrakanal Pada Perawatan Saluran Akar. Mderj. 2021;1(3):157-170.
  11. Ayu P, Dewi K, Nurhapsari A, Yusuf M. The Effect of Three Intracanal Medicament Products on Pseudomonas Aeruginosa. Mesina. 2021;2:16-21.
  12. Garg NGA. Textbook of. Third Edit. New Delhi, India: Jaypee Brothers Medical Publishers (P) Ltd; 2015. 420–425 p.
  13. Sinha D, Sinha A. Natural medicaments in dentistry. AYU (An Int Q J Res Ayurveda). 2014;35(2):113.
  14. Pakaya D, Dewi M, Antari AL, Saraswati I. Ekstrak Hibiscus rosa-sinensis L. Memperbaiki Kadar Glukosa Darah Puasa dan Jumlah Sel Mast pada Model Tikus Diabetes Terinfeksi Mycobacterium tuberculosis. J Farm Galen (Galenika J Pharmacy). 2020;6(1):14–9.
  15. Julia D, Salni S, Nita S. Pengaruh Ekstrak Bunga Kembang Sepatu (Hibiscus Rosa-Sinensis Linn.) Terhadap Jumlah, Motilitas, Morfologi, Vabilitas Spermatozoa Tikus Jantan (Rattus Norvegicus). Biomed J Indones J Biomedik Fak Kedokt Univ Sriwij. 2019;5(1):34–42.
  16. Parengkuan H, Wowor VNS, Pangemanan DHC. Uji Daya Hambat Ekstrak Bunga Kembang Sepatu (Hibiscus rosa-sinensis L.) terhadap Pertumbuhan Bakteri Streptococcus mutans. e-GiGi. 2020;8(1):8–14.
  17. Victoria J, Arunmozhi V. Antibacterial activity of hibiscus rosa-sinensis and rosa-damascena petals against dental pathogens. Int J Integr Sci Innov Technol. 2014;3(3):1–6.
  18. Kumar A, Tamanna S, Iftekhar H. Intracanal medicaments – Their use in modern endodontics: A narrative review. J Oral Res Rev. 2019;11:89–94.
  19. Syafriza D, Sutadi H, Primasari A, Siregar Y. Spectrophotometric analysis of streptococcus mutans growth and biofilm formation in Saliva and histatin-5 relate to pH and viscosity. Pesqui Bras Odontopediatria Clin Integr. 2020;21:1–11.
  20. Mikrobiologi Analitik. Makassar: Alauddin Univ Press. 2014;1(1):1–242.
  21. Septiani S, Dewi EN, Wijayanti I. Aktivitas Antibakteri Ekstrak Lamun (Cymodocea rotundata) terhadap Bakteri Staphylococcus aureus dan Escherichia coli (Antibacterial Activities of Seagrass Extracts (Cymodocea rotundata) Against Staphylococcus aureus and Escherichia coli). SAINTEK Perikan Indones J Fish Sci Technol. 2017;13(1):1
  22. Prima Fetri cary; Saadah, Ulia Nailis SR munarsih. Perbandingan Jenis, Komposisi dan Jumlah Pelarut Terhadap Uji Total Flavonoid dari Daun Jawer Kotok (Plectranthus scutellarioides(L.) R.Br.). J Farm Higea. 2018;10(Vol 10, No 2 (2018)):154-162.24.
  23. Up S, Tandon T, Dj S. Apical Periodontitis - Virulence Factors of Enterococcus faecalis and Candida albicans. Austin Journal of Dentistry. 2020;7(4).
  24. Vineet R V, Nayak M. Enterococcus faecalis : An Enigma in Root Canal Infections. Int Res J Pharm Biosci. 2016;3(1):12–21.
  25. Kumar A, Tamanna S, Iftekhar H. Oral Health Status of Martyr Memorial Residential School. J Oral Res Rev. 2019;11:89–94.
  26. Pratiwi RH. “Mekanisme Pertahanan Bakteri Patogen Terhadap Antibiotik.” J Pro-Life. 2017;4(3):418–29.
  27. Trisia A, Philyria R, Toemon AN. Uji Aktivitas Antibakteri Ekstrak Etanol Daun Kalanduyung (Guazuma ulmifolia Lam.) terhadap Pertumbuhan Staphylococcus aureus dengan Metode Difusi Cakram (KIRBY-BAUER). Anterior J. 2018;17(2):136-143.
  28. Rachmawati HD, Aprilia, Parisihni K. The Effectivity of Antibacterial of Mangrove Acanthus ilicifolius Leaves Extract on Biofilm Enterococcus faecalis. Denta-Journal. 2015;9(2):1–6.

Additional Files

Published

2023-03-31

How to Cite

1.
Choirunnisa E, Wibowo GW, Antari AL, Purnomo BNR. Potential Of Hibiscus (Hibiscus rosa sinensis L.) Ethanol Extract As Root Canal Medicament Materials. Medica Hospitalia J. Clin. Med. [Internet]. 2023 Mar. 31 [cited 2024 May 3];10(1):57-62. Available from: http://medicahospitalia.rskariadi.co.id/medicahospitalia/index.php/mh/article/view/809

Issue

Vol. 10 No. 1 (2023): Med Hosp; March 2023

Section

Original Article

Citation Check

License

Copyright (c) 2023 Efika Choirunnisa

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Copyrights Notice
Copyrights:
Researchers publishing manuscrips at Medica Hospitalis: Journal of Clinical Medicine agree with regulations as follow:
Copyrights of each article belong to researchers, and it is likewise the patent rights
Researchers admit that Medica Hospitalia: Journal of Clinical Medicine has the right of first publication
Researchers may submit manuscripts separately, manage non exclusive distribution of published manuscripts into other versions (such as: being sent to researchers’ institutional repository, publication in the books, etc), admitting that manuscripts have been firstly published at Medica Hospitalia: Journal of Clinical Medicine
License:
Medica Hospitalia: Journal of Clinical Medicine is disseminated based on provisions of Creative Common Attribution-Share Alike 4.0 Internasional It allows individuals to duplicate and disseminate manuscripts in any formats, to alter, compose and make derivatives of manuscripts for any purpose. You are not allowed to use manuscripts for commercial purposes. You should properly acknowledge, reference links, and state that alterations have been made. You can do so in proper ways, but it does not hint that the licensors support you or your usage.